Becton, Dickinson & Company (NYSE:BDX) is facing allegations that it abused monopoly power in the U.S. hernia mesh market to block competition, raise costs for hospitals, and limit treatment choices for patients, according to a lawsuit brought by small-cap firm…
Cardano (CRYPTO: ADA) founder Charles Hoskinson and Solana (CRYPTO: SOL) co-founder Anatoly Yakovenko have agreed to build a bridge between their blockchains, ending years of hostility between two tribes. Yakovenko Ends The Tribal War Yakovenko made the first move, saying…
Editor’s Note: This story has been updated to include additional U.S. economic data for the third quarter of 2025. The U.S. economy continued to show an exceptional resilience in the third quarter. Gross domestic product (GDP) expanded at an annualized…
On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, named Toast, Inc. (NYSE:TOST) as his final trade. Supporting his view, JPMorgan analyst Tien-Tsin Huang, on Dec. 4, upgraded Toast from Neutral to Overweight and…
On December 19, 2025, the Bank of Japan (BOJ) (8301.T) raised its key interest rate to 0.75%, representing the highest increase since 1995. In a not so hawkish tone, BOJ reiterated that the current wage‑price momentum justified the hike as…
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Evercore ISI Group analyst Robert Ottenstein downgraded Coty Inc…
As of Dec. 23, 2025, two stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s…
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Piper Sandler analyst Crispin Love upgraded SEI Investments Co…
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B of A Securities raised ArcBest Corporation (NASDAQ:ARCB) price target…
Neurocrine Biosciences Inc. (NASDAQ:NBIX) on Monday shared data from its Phase 3 KINECT-DCP study evaluating the efficacy, safety, and tolerability of valbenazine in pediatric and adult participants who have dyskinetic cerebral palsy (DCP). Cerebral palsy (CP) is a nonprogressive neurodevelopmental…